Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells-Reference-Cited by-同舟云学术

Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells

Published:2017-09-21 Issue:1 Volume:7 Page:e1373231
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Shime Hiroaki¹²,Maruyama Akira¹,Yoshida Sumito¹,Takeda Yohei¹^ORCID,Matsumoto Misako¹,Seya Tsukasa¹

Affiliation:

1. Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Kita 15 Nishi 7, Kita-ku, Sapporo, Japan

2. Department of Immunology, Graduate School of Medical Sciences, Nagoya City University, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1373231

Reference43 articles.

1. Innate and adaptive immune cells in the tumor microenvironment

2. The role of myeloid cells in cancer therapies

3. Adjuvant engineering for cancer immunotherapy: Development of a synthetic TLR2 ligand with increased cell adhesion

4. Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDSCs use a complex molecular network to suppress T-cell immunity in a pulmonary model of fungal infection;Frontiers in Cellular and Infection Microbiology;2024-07-05

2. TLR9 promotes monocytic myeloid-derived suppressor cell induction during JEV infection;Microbes and Infection;2024-07

3. Cholestasis-induced phenotypic transformation of neutrophils contributes to immune escape of colorectal cancer liver metastasis;Journal of Biomedical Science;2024-06-29

4. Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer;Cancer Letters;2024-04

5. Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment;Exploration of Targeted Anti-tumor Therapy;2024-02-28